UNSPSC 51282811: Metronidazole hydrochloride

This classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula C6H9N3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 76JC1633UF, chemically known as 1h-imidazole-1-ethanol, 2-methyl-5-nitro-, hydrochloride but more generally known as metronidazole hydrochloride, which bears US NIH Compound Identifier 68592. European Medicines Agency schedules Metronidazole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14570MIG.

UNSPSC 51282811 Metronidazole hydrochloride is a Commodity code that captures state and local procurement of specific pharmaceutical products and related medical supplies. However, the recent solicitations tagged under this code show substantial divergence from the code's nominal scope. The Seminole County, Florida opportunity targets naloxone and drug deactivation systems; the City of Tampa solicitation seeks emergency medical and first aid supplies including respiratory equipment, cardiac monitoring devices, and airway management consumables; and the Minnesota MMCAP RFP addresses generic multi-source pharmaceuticals and OTC products broadly. Only the Texas HHS Commission RFI addresses direct-to-manufacturer prescription fulfillment programs that might encompass metronidazole in a broader pharmacy benefit context. Issuing bodies include county health departments (Seminole County), municipal fire and rescue services (Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota MMCAP). The code shows minimal coherence around metronidazole specifically; instead, it reflects fragmented state and local purchasing of emergency medical supplies, pharmacy benefit products, and OTC items across distinct procurement vehicles.

Geographic activity appears concentrated in Florida and Minnesota, with additional engagement from Texas and Oregon (through MMCAP). Representative recent opportunities include Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's bid 26P00145 for medical and first aid supplies to the Tampa Fire Department Rescue Division, due March 13, 2026, estimated at $700,000 and designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota MMCAP RFP S1070000015802 for generic pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The code reflects no concentrated repeat buyer and limited recent activity directly aligned with metronidazole procurement; the divergence between code nomenclature and actual solicitation scope suggests the category may see sporadic or mislabeled tagging in state and local systems.